What if you could drive smarter decisions across every stage of the commercial lifecycle?
Creating and implementing agile, data-driven commercial strategies is complex. Backed by unrivalled data, advanced analytics and AI, and domain expertise, IQVIA Commercial Solutions helps you improve and accelerate decision-making to enhance HCP impact and patient outcomes.
Data & Information Management
Take advantage of the latest tools, unmatched data and deep healthcare expertise to create scalable resources, precision insights and actionable ideas.
Analytics & Consulting
Gain confidence with advanced analytics and precision insights to deliver better processes, business outcomes and commercial results.
HCP & Patient Engagement
Leverage real-time insights and AI-driven solutions to connect with HCPs and patients, ensuring effective engagement, improved patient outcomes and rapid response to market dynamics.
With over three decades of experience and a deep analysis of over 1000 innovative launches, IQVIA knows what it takes to achieve launch excellence. IQVIA offers end-to-end strategic support throughout launch planning, execution and monitoring.
Sustained growth of mature brands requires a different approach. IQVIA Established Brands Optimization is a consultative method to reinvigorate brand profitably in late commercial phases, focusing on analytics, field resourcing and marketing services.
White Paper
AI is no longer experimental, it’s essential
2025 Everest Group Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Report
IQVIA has been recognized as a Leader in the 2025 Everest Group Life Sciences AI and Analytics Services for Commercial PEAK Matrix® Assessment. This comprehensive report evaluates 30 global providers based on their market impact and ability to deliver AI and analytics services across the commercialization lifecycle.
Ebook
Overcoming 7 Top Challenges
The increasingly competitive digital and complex nature of an omnichannel ecosystem invites many new challenges. With higher media spend but low confidence in whether those dollars are working, many biopharma executives worry that forces like business silos, limited data exchange, and disparate technologies are holding them back. Learn how practical strategies can address these persistent issues.
Explore More
End-to-end Commercial Solutions
